Bluejay Cost Of Revenue vs Gross Profit Analysis

BJDX Stock

USD 3.52 0.02 0.57%

Bluejay Diagnostics financial indicator trend analysis is way more than just evaluating Bluejay Diagnostics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bluejay Diagnostics is a good investment. Please check the relationship between Bluejay Diagnostics Cost Of Revenue and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluejay Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Cost Of Revenue vs Gross Profit

Cost Of Revenue vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bluejay Diagnostics Cost Of Revenue account and Gross Profit. At this time, the significance of the direction appears to have pay attention.

The correlation between Bluejay Diagnostics' Cost Of Revenue and Gross Profit is -0.96. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Bluejay Diagnostics, assuming nothing else is changed. The correlation between historical values of Bluejay Diagnostics' Cost Of Revenue and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Bluejay Diagnostics are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Cost Of Revenue i.e., Bluejay Diagnostics' Cost Of Revenue and Gross Profit go up and down completely randomly.

Correlation Coefficient

-0.96

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Bluejay Diagnostics income statement and represents the costs associated with goods and services Bluejay Diagnostics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bluejay Diagnostics minus its cost of goods sold. It is profit before Bluejay Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Bluejay Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bluejay Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluejay Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.Selling General Administrative is likely to drop to about 2.7 M in 2024. Issuance Of Capital Stock is likely to drop to about 1.5 M in 2024

	2021	2022	2023	2024 (projected)
Total Operating Expenses	3.2M	9.4M	10.3M	5.6M
Cost Of Revenue	145.7K	200.1K	781.0K	820.0K

Total Operating Expenses Cost Of Revenue

Bluejay Diagnostics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.81	0.46	0.32	0.99	0.92	0.28	0.69	-0.97	-0.49	0.66	0.96	0.29	0.84	-0.24	0.96	0.8	-0.72	-0.83	-0.84	0.94	0.94	-0.86	0.98	0.23	0.7
Short Long Term Debt Total	-0.81		-0.87	-0.64	-0.81	-0.95	-0.7	-0.85	0.72	0.87	-0.86	-0.7	-0.71	-0.98	0.56	-0.7	-0.98	0.82	0.98	0.97	-0.94	-0.94	0.86	-0.79	-0.69	-0.85
Other Current Liab	0.46	-0.87		0.86	0.46	0.7	0.89	0.84	-0.35	-0.92	0.9	0.32	0.89	0.85	-0.59	0.32	0.86	-0.79	-0.81	-0.85	0.72	0.67	-0.54	0.42	0.84	0.83
Total Current Liabilities	0.32	-0.64	0.86		0.26	0.44	0.67	0.85	-0.21	-0.75	0.91	0.19	0.68	0.7	-0.5	0.19	0.69	-0.86	-0.54	-0.72	0.52	0.45	-0.17	0.23	0.7	0.85
Total Stockholder Equity	0.99	-0.81	0.46	0.26		0.93	0.29	0.67	-0.99	-0.45	0.62	0.98	0.31	0.81	-0.14	0.98	0.76	-0.67	-0.81	-0.8	0.93	0.94	-0.88	1.0	0.17	0.68
Net Tangible Assets	0.92	-0.95	0.7	0.44	0.93		0.49	0.79	-0.88	-0.69	0.74	0.86	0.51	0.92	-0.38	0.86	0.91	-0.76	-0.93	-0.92	0.96	1.0	-0.93	0.92	0.45	0.79
Property Plant And Equipment Net	0.28	-0.7	0.89	0.67	0.29	0.49		0.55	-0.16	-0.81	0.74	0.13	1.0	0.65	-0.47	0.13	0.67	-0.49	-0.68	-0.64	0.59	0.45	-0.46	0.26	0.8	0.54
Current Deferred Revenue	0.69	-0.85	0.84	0.85	0.67	0.79	0.55		-0.65	-0.72	0.93	0.63	0.56	0.88	-0.38	0.63	0.85	-0.98	-0.75	-0.89	0.79	0.8	-0.52	0.65	0.53	1.0
Net Debt	-0.97	0.72	-0.35	-0.21	-0.99	-0.88	-0.16	-0.65		0.32	-0.56	-1.0	-0.17	-0.73	0.03	-1.0	-0.68	0.65	0.71	0.73	-0.87	-0.9	0.8	-0.99	-0.03	-0.65
Retained Earnings	-0.49	0.87	-0.92	-0.75	-0.45	-0.69	-0.81	-0.72	0.32		-0.82	-0.28	-0.82	-0.88	0.84	-0.28	-0.91	0.72	0.88	0.87	-0.71	-0.69	0.63	-0.41	-0.95	-0.71
Accounts Payable	0.66	-0.86	0.9	0.91	0.62	0.74	0.74	0.93	-0.56	-0.82		0.54	0.75	0.91	-0.48	0.54	0.88	-0.94	-0.8	-0.91	0.83	0.74	-0.53	0.6	0.67	0.93
Cash	0.96	-0.7	0.32	0.19	0.98	0.86	0.13	0.63	-1.0	-0.28	0.54		0.14	0.7	0.02	1.0	0.64	-0.62	-0.68	-0.7	0.85	0.88	-0.78	0.99	-0.01	0.63
Non Current Assets Total	0.29	-0.71	0.89	0.68	0.31	0.51	1.0	0.56	-0.17	-0.82	0.75	0.14		0.66	-0.47	0.14	0.68	-0.5	-0.69	-0.65	0.6	0.46	-0.47	0.27	0.8	0.55
Non Currrent Assets Other	0.84	-0.98	0.85	0.7	0.81	0.92	0.65	0.88	-0.73	-0.88	0.91	0.7	0.66		-0.61	0.7	0.99	-0.89	-0.97	-1.0	0.95	0.93	-0.81	0.78	0.7	0.88
Long Term Debt	-0.24	0.56	-0.59	-0.5	-0.14	-0.38	-0.47	-0.38	0.03	0.84	-0.48	0.02	-0.47	-0.61		0.02	-0.68	0.47	0.63	0.6	-0.37	-0.41	0.39	-0.1	-0.9	-0.37
Cash And Short Term Investments	0.96	-0.7	0.32	0.19	0.98	0.86	0.13	0.63	-1.0	-0.28	0.54	1.0	0.14	0.7	0.02		0.64	-0.62	-0.68	-0.7	0.85	0.88	-0.78	0.99	-0.01	0.63
Net Receivables	0.8	-0.98	0.86	0.69	0.76	0.91	0.67	0.85	-0.68	-0.91	0.88	0.64	0.68	0.99	-0.68	0.64		-0.86	-0.98	-0.99	0.92	0.91	-0.81	0.74	0.75	0.84
Common Stock Shares Outstanding	-0.72	0.82	-0.79	-0.86	-0.67	-0.76	-0.49	-0.98	0.65	0.72	-0.94	-0.62	-0.5	-0.89	0.47	-0.62	-0.86		0.75	0.91	-0.79	-0.78	0.5	-0.64	-0.55	-0.98
Non Current Liabilities Total	-0.83	0.98	-0.81	-0.54	-0.81	-0.93	-0.68	-0.75	0.71	0.88	-0.8	-0.68	-0.69	-0.97	0.63	-0.68	-0.98	0.75		0.96	-0.94	-0.93	0.91	-0.79	-0.71	-0.75
Inventory	-0.84	0.97	-0.85	-0.72	-0.8	-0.92	-0.64	-0.89	0.73	0.87	-0.91	-0.7	-0.65	-1.0	0.6	-0.7	-0.99	0.91	0.96		-0.94	-0.93	0.79	-0.78	-0.69	-0.89
Other Current Assets	0.94	-0.94	0.72	0.52	0.93	0.96	0.59	0.79	-0.87	-0.71	0.83	0.85	0.6	0.95	-0.37	0.85	0.92	-0.79	-0.94	-0.94		0.96	-0.89	0.92	0.49	0.79
Other Stockholder Equity	0.94	-0.94	0.67	0.45	0.94	1.0	0.45	0.8	-0.9	-0.69	0.74	0.88	0.46	0.93	-0.41	0.88	0.91	-0.78	-0.93	-0.93	0.96		-0.92	0.93	0.45	0.8
Total Liab	-0.86	0.86	-0.54	-0.17	-0.88	-0.93	-0.46	-0.52	0.8	0.63	-0.53	-0.78	-0.47	-0.81	0.39	-0.78	-0.81	0.5	0.91	0.79	-0.89	-0.92		-0.87	-0.43	-0.52
Net Invested Capital	0.98	-0.79	0.42	0.23	1.0	0.92	0.26	0.65	-0.99	-0.41	0.6	0.99	0.27	0.78	-0.1	0.99	0.74	-0.64	-0.79	-0.78	0.92	0.93	-0.87		0.13	0.66
Property Plant And Equipment Gross	0.23	-0.69	0.84	0.7	0.17	0.45	0.8	0.53	-0.03	-0.95	0.67	-0.01	0.8	0.7	-0.9	-0.01	0.75	-0.55	-0.71	-0.69	0.49	0.45	-0.43	0.13		0.52
Short Long Term Debt	0.7	-0.85	0.83	0.85	0.68	0.79	0.54	1.0	-0.65	-0.71	0.93	0.63	0.55	0.88	-0.37	0.63	0.84	-0.98	-0.75	-0.89	0.79	0.8	-0.52	0.66	0.52

Click cells to compare fundamentals

Bluejay Diagnostics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Bluejay Stock Analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bluejay Cost Of Revenue vs Gross Profit Analysis

Cost Of Revenue vs Gross Profit

Cost Of Revenue vs Gross Profit Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Gross Profit

Bluejay Diagnostics fundamental ratios Correlations

Bluejay Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Bluejay Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Other Stockholder Equity	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Short Long Term Debt	+ 1.0	Current Deferred Revenue
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets

Inventory	- 1.0	Non Currrent Assets Other
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Inventory	- 0.99	Net Receivables
Net Invested Capital	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity